Patent · US Expired

Use of inhibitors of the activity of retinoic acid for treating sensit ive skin and/or acute damage induced by UV radiation

US6248749A · kind A · utility

13Cited by

16References

7Claims

0Family size

Assignee

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · FR

Inventors

Michel Demarchez · Grasse, FR
Andre Jomard · Grasse, FR

Key dates

Filing date	Sep 4, 1998
Grant date	Jun 19, 2001
Priority date	—
Expiry date	Sep 4, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q17/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns tye use of a inhibitor of retinoic acid as sole ingredient in a pharmaceutical or cosmetic composition comprising administering effective amount of the composition to treat sensitive skin or skin damage induced by UV radiation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.